Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 2, 2007, Pages

  Yaras, Nazmi ^a   Bilginoglu, Ayca ^a   Vassort, Guy ^b   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Candesartan; Heart; Thiol oxidation; Type 1 diabetes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BINDING PROTEIN; BISINDOLYLMALEIMIDE; CALCIUM ION; CANDESARTAN; ENZYME; PROTEIN KINASE; RYANODINE RECEPTOR; TACROLIMUS; THIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE CELL; HEART PROTECTION; INCUBATION TIME; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BLOCKING; SARCOPLASMIC RETICULUM; SPATIAL DISCRIMINATION; STREPTOZOCIN DIABETES; TEMPERATURE DEPENDENCE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; CAFFEINE; CALCIUM; CALCIUM SIGNALING; CARDIOMYOPATHIES; DIABETES MELLITUS, EXPERIMENTAL; INDOLES; KINETICS; MALE; MALEIMIDES; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEINS; RATS; RATS, WISTAR; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SULFHYDRYL COMPOUNDS; TACROLIMUS BINDING PROTEINS; TETRAZOLES;

EID: 33846977064     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00824.2006     Document Type: Article

References (51)

1. Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 426: 83-90, 2004.
2. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol 54: 227-241, 1992.
3. Bidasee KR, Dincer UD, Besch HR. Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats. Mol Pharmacol 60: 1356-1364, 2001.
4. Bidasee KR, Nallani Besch HR K Jr, Dincer UD. Streptozotocin- induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). J Pharmacol Exp Ther 305: 989-998, 2003.
5. Bouchard RA, Bose D. Influence of experimental diabetes on sarcoplasmic reticulum function in rat ventricular muscle. Am J Physiol Heart Circ Physiol 260: H341-H354, 1991.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
7. 2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283: H1398-H1408, 2002.
8. Danser AH, Saris JJ, Schuijt MP, van Kats JP. Is there a local renin-angiotensin system in the heart? Cardiovasc Res 44: 252-265, 1999.
9. Davidoff AJ, Davidson MB, Carmody MW, Davis ME, Ren J. Diabetic cardiomyocyte dysfunction and myocyte insulin resistance: role of glucose-induced PKC activity. Mol Cell Biochem 262: 155-163, 2004.
10. De Lannoy LM, Danser AH, Bouhuizen AM, Saxena PR, Schalekamp MA. Localization and production of angiotensin II in the isolated perfused rat heart. Hypertension 31: 1111-1117, 1998.
11. Dostal DE. The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function. Regul Pept 91: 1-11, 2000.
12. Dostal DE, Rothblum KN, Chernin MI, Cooper GR, Baker KM. Intracardiac detection of angiotensinogen and renin: a localized reninangiotensin system in neonatal rat heart. Am J Physiol Cell Physiol 263: C838-C850, 1992.
13. Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37: 1047-1052, 2001.
14. Endoh M. The effects of various drugs on the myocardial inotropic response. Gen Pharmacol 26: 1-31, 1995.
15. Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab Invest 80: 513-527, 2000.
16. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol Endocrinol Metab 244: E528-E535, 1983.
17. Gassanov N, Brandt MC, Michels G, Lindner M, Er F, Hoppe UC. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium 39: 175-186, 2006.
18. Haddad GE, Coleman BR, Zhao A, Blackwell KN. Modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy. Basic Res Cardiol 99: 317-327, 2004.
19. Hanatani A, Yoshiyama M, Takeuchi K, Kim S, Nakayama K, Omura T, Iwao H, Yoshikawa J. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats. Jpn J Pharmacol 78: 45-54, 1998.
20. 2+ regulation in isolated ferret ventricular myocytes. Pflügers Arch 437: 529-537, 1999.
21. 2+ handling in streptozotocin-induced diabetic rat myocardium. Am J Physiol Heart Circ Physiol 277: H2185-H2194, 1999.
22. 2+ channels (CaV1.2a,b) by protein kinases. Am J Physiol Cell Physiol 281: C1743-C1756, 2001.
23. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 65: 1170-1179, 2004.
24. Mackay K, Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J Mol Cell Cardiol 33: 1301-1307, 2001.
25. Malhotra A, Kang BPS, Cheung S, Opawumi D, Meggs LG. Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes 50: 1918-1926, 2001.
26. Malhotra A, Reich D, Nakouzi A, Sanghi V, Geenen DL, Buttrick PM. Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 81: 1027-1033, 1997.
27. Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol 33: 615-624, 2001.
28. 1 receptor regulation. Circulation 105: 530-536, 2000.
29. Okuda S, Yano M, Doi M, Oda T, Tokuhisa T, Kohno M, Kobayashi S, Yamamoto T, Ohkusa T, Matsuzaki M. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure. Circulation 109: 911-919, 2004.
30. 2+ transients and contractile function of rat myocardium. Arch Biochem Biophys 435: 166-174, 2005.
31. Palomeque J, Sapia L, Hajjar RJ, Mattiazzi A, Petroff MV. Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. Am J Physiol Heart Circ Physiol 290: H96-H106, 2006.
32. Pierce GN, Dhalla NS. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol Endocrinol Metab 248: E170-E175, 1985.
33. 1 receptor and NADPH oxidase. Hypertension 42: 206-212, 2003.
34. Raimondi L, Paoli PD, Mannucci E, Lonardo G, Sartiani L, Banchelli G, Pirisino R, Mugelli A, Cerbai E. Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats. Diabetes 53: 1927-1933, 2004.
35. Reiken S, Gaburjakova M, Gaburjakova J, He Kl KL, Prieto A, Becker E, Yi Gh GH, Wang J, Burkhoff D, Marks AR. β-Adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 104: 2843-2848, 2001.
36. 2+ accumulation in cardiac sarcoplasmic reticulum. J Biol Chem 265: 4302-4308, 1990.
37. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30: 595-602, 1972.
38. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993.
39. Schmieder RE. Mechanisms for the clinical benefits of angiotensin II receptor blockers. Am J Hypertens 18: 720-730, 2005.
40. Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 43: 1180-1184, 1994.
41. + currents in rat ventricular myocytes and its modification by hormonal status. J Physiol 520: 439-449, 1999.
42. + currents in type 1 and type 2 diabetes. J Physiol 555: 345-354, 2001.
43. Shimoni Y, Hunt D, Chuang M, Chen KY, Kargacin G, Severson DL. Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat. J Physiol 567: 177-190, 2005.
44. 2+ movements. Cardiovasc Res 32: 352-361, 1996 .
45. Van der Velden J, Narolska NA, Lamberts RR, Boontje NM, Borbely A, Zaremba R, Bronzwaer JG, Papp Z, Jaquet K, Paulus WJ, Stienen GJ. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. Cardiovasc Res 69: 876-887, 2006.
46. Watanuki S, Matsuda N, Sakuraya F, Jesmin S, Hattori Y. Protein kinase C modulation of the regulation of sarcoplasmic reticular function by protein kinase A-mediated phospholamban phosphorylation in diabetic rats. Br J Pharmacol 141: 347-359, 2004.
47. Wold LE, Ceylan-Isik AF, Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 26: 908-917, 2005.
48. + channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res 53: 80-88, 2002.
49. Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Ohkusa T, Kohno M, Matsuzaki M. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107: 477-484, 2003.
50. Yano M, Yamamoto T, Ikeda Y, Matsuzaki M. Mechanisms of disease: ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 3: 43-52, 2006.
51. 2+ homeostasis in rat heart. Diabetes 54: 3082-3088, 2005.